Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Lacticaseibacillus Rhamnosus GG Supplementation Does Not Reduce Disease Activity, CRP or ESR Beyond Placebo in Active Ankylosing Spondylitis: A Randomized, Double-Blind Trial

NCT07834788 is registered in ClinicalTrials.gov with Acibadem University as lead sponsor.

NCT NCT07834788
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07834788 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Lacticaseibacillus Rhamnosus GG Supplementation Does Not Reduce Disease Activity, CRP or ESR Beyond Placebo in Active Ankylosing Spondylitis: A Randomized, Double-Blind Trial
Lead sponsor
Acibadem University
Phase
Not applicable
Overall status
Completed
Start date
October 1, 2018
Completion date
March 1, 2019
Enrollment
31 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ankylosing spondylitis